Enhancing long-term smoking abstinence among individuals with a history of cervical intraepithelial neoplasia or cervical cancer (Project ACCESS): protocol for a randomized clinical trial

This study builds on promising results from our recent trial which found that MAPS was associated with substantially higher abstinence from smoking at the end of the 12-month treatment period. Finding that this low-burden, personally tailored digital treatment adjuvant improves the long-term efficacy of MAPS would have important clinical and public health implications.TRIAL REGISTRATION: Clinical Trials Registry NCT05645146; https://clinicaltrials.gov/ct2/show/NCT05645146 ; Registered on December 9, 2022.PMID:37403057 | DOI:10.1186/s12889-023-16189-3

Source: Cancer Control - July 4, 2023 Category: Cancer & Oncology Authors: Jennifer I Vidrine Bethany Shorey Fennell Vani N Simmons Steven K Sutton Sarah R Jones Honor W Woodward Charles E Hoogland Damon J Vidrine Source Type: research